Bristol-Myers introduced CEENUᆴ (lomustine), a chemotherapy product for brain cancer and Hodgkins lymphoma

In 1976, Bristol-Myers introduced CEENUᆴ (lomustine), a chemotherapy product for brain cancer and Hodgkins lymphoma.

Tags:


Source: Bristol-Myers Squibb Company
Credit: